Radiation Technology, Inc.

As of June 30, 2024, Radiation Technology, Inc. has 30.02M shares outstanding.

As of June 30, 2024, Radiation Technology, Inc. trades at a trailing price-to-earnings ratio of 16.18. The price-to-sales ratio is 2.74, and the price-to-book ratio stands at 3.58.

As of June 30, 2024, Radiation Technology, Inc. trades at an EV/EBITDA multiple of 10.05 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.59 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 10.05 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Radiation Technology, Inc. trades at an EV/FCF ratio of 12.50, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of June 30, 2024, Radiation Technology, Inc. maintains a current ratio of 3.10, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2024, Radiation Technology, Inc. posted a return on equity (ROE) of 22.10, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 11.00 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 10.06, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 22.10, useful for judging operating efficiency across full business cycles. Inventory turnover of 6.23 indicates how many times Radiation Technology, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

These figures cover the twelve months ended June 30, 2024. That works out to an effective tax rate of 18.68, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

As of the close on October 16, 2024, Radiation Technology, Inc.'s stock has gained approximately 2.73% over the past 52 weeks. The 50-day moving average sits at 50.61, while the 200-day moving average is 51.61.

Over the twelve months ended June 30, 2024, Radiation Technology, Inc. posted a gross margin of 29.18, reflecting its pricing power and cost economics. The operating margin of 15.85 and net profit margin of 16.93 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2024. Free cash flow yield stands at 4.64, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 7.00, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Radiation Technology, Inc. shareholders.

Radiation Technology, Inc.'s most recent stock split took place on July 16, 2019 with a 500:611 split ratio.

As of June 30, 2024, Radiation Technology, Inc. has an Altman Z-Score of 4.81, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.